R21/Matrix-M: WHO recommends Malaria vaccine made by Oxford and Serum Institute of India
The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality & effectiveness standards.
R21/Matrix-M, developed by Britain's University of Oxford, will become available by mid-2024, The doses would cost cost between $2 & $4.
Did you Know
WHO chief :Tedros Adhanom Ghebreyesus.